128 related articles for article (PubMed ID: 24975097)
1. Effect of cyclooxygenase (COX)-2 inhibition on mouse renal interstitial fibrosis.
Honma S; Shinohara M; Takahashi N; Nakamura K; Hamano S; Mitazaki S; Abe S; Yoshida M
Eur J Pharmacol; 2014 Oct; 740():578-83. PubMed ID: 24975097
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction.
Moriyama T; Kawada N; Ando A; Yamauchi A; Horio M; Nagata K; Imai E; Hori M
Kidney Int; 1998 Jul; 54(1):110-9. PubMed ID: 9648069
[TBL] [Abstract][Full Text] [Related]
3. Effect of amlodipine on mouse renal interstitial fibrosis.
Honma S; Nakamura K; Shinohara M; Mitazaki S; Abe S; Yoshida M
Eur J Pharmacol; 2016 Jun; 780():136-41. PubMed ID: 27029240
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclooxygenase-2 in the development of interstitial fibrosis in kidneys following unilateral ureteral obstruction in mice.
Kamata M; Hosono K; Fujita T; Kamata K; Majima M
Biomed Pharmacother; 2015 Mar; 70():174-80. PubMed ID: 25776498
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
Honma S; Takahashi N; Shinohara M; Nakamura K; Mitazaki S; Abe S; Yoshida M
Eur J Pharmacol; 2013 Sep; 715(1-3):181-8. PubMed ID: 23747596
[TBL] [Abstract][Full Text] [Related]
6. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephropathy.
Moriyama T; Kawada N; Akagi Y; Ando A; Horio M; Yamauchi A; Nagata K; Imai E; Hori M
Kidney Int Suppl; 1997 Dec; 63():S232-5. PubMed ID: 9407468
[TBL] [Abstract][Full Text] [Related]
7. Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47.
Xia Z; Abe K; Furusu A; Miyazaki M; Obata Y; Tabata Y; Koji T; Kohno S
Am J Nephrol; 2008; 28(1):34-46. PubMed ID: 17890856
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 mitogen-activated protein kinases attenuates renal interstitial fibrosis in a murine unilateral ureteral occlusion model.
Gao F; Wang Y; Li S; Wang Z; Liu C; Sun D
Life Sci; 2016 Dec; 167():78-84. PubMed ID: 27773718
[TBL] [Abstract][Full Text] [Related]
9. [The renal protective effect of selective cyclooxygenase-2 inhibitor on obstructive nephropathy].
Zuo Y; Ma J; Gu Y; Yang H; Lin S
Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):825-8. PubMed ID: 12654237
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitor decreases extracellular matrix synthesis in stretched renal fibroblasts.
El Chaar M; Attia E; Chen J; Hannafin J; Poppas DP; Felsen D
Nephron Exp Nephrol; 2005; 100(4):e150-5. PubMed ID: 15849480
[TBL] [Abstract][Full Text] [Related]
11. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
12. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
13. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
[TBL] [Abstract][Full Text] [Related]
14. [Modulation of aberrant extracellular matrix degradation systems by astragali radix and angelicae sinensis radix decoction (A&A) in interstitial fibrotic kidney].
Meng L; Liao A; Qu L; Tang J; Li X
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):79-84. PubMed ID: 22741467
[TBL] [Abstract][Full Text] [Related]
15. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W
J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
17. ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney.
Ma FY; Tesch GH; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1263-73. PubMed ID: 25298527
[TBL] [Abstract][Full Text] [Related]
18. Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction.
Koike K; Ueda S; Yamagishi S; Yasukawa H; Kaida Y; Yokoro M; Fukami K; Yoshimura A; Okuda S
Clin Immunol; 2014 Jan; 150(1):78-87. PubMed ID: 24333535
[TBL] [Abstract][Full Text] [Related]
19. Semaporin3A inhibitor ameliorates renal fibrosis through the regulation of JNK signaling.
Sang Y; Tsuji K; Fukushima K; Takahashi K; Kitamura S; Wada J
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F740-F756. PubMed ID: 34747196
[TBL] [Abstract][Full Text] [Related]
20. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren.
Wu WP; Chang CH; Chiu YT; Ku CL; Wen MC; Shu KH; Wu MJ
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F929-41. PubMed ID: 20685818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
